A unique, curated database and intelligence platform covering process patents for marketed pharmaceutical drugs — offering text search, enhanced structure search, and targeted patent data not readily replicated from standard commercial databases.
| INN / Drug | Records |
|---|
As a marketed pharmaceutical drug approaches the end of its product patent term, a wave of process patents are filed — covering synthetic routes, key intermediates, and manufacturing improvements designed to secure commercial advantage when the drug goes generic.
These process patents are not listed by the FDA or EMA. They are buried within high-cost general patent databases alongside thousands of unrelated filings. Finding, interpreting, and tracking them is enormously time-consuming without specialist expertise.
The Claimed Intermediate database solves this problem directly: every record is identified, read, and abstracted by a pharmaceutical patent expert, then made fully searchable by drug name, intermediate structures, patentee, major jurisdictions, etc.
Search by drug INN, patentee name, or draw a chemical structure directly in the browser. Find exact matches, similarity, derivative, or substructure hits across thousands of records.
Every patent record is individually reviewed and abstracted — not auto-scraped. The database surfaces drug synthetic routes often buried across hundreds of filings, presented in a clear visual format.
Understand which pharmaceutical synthetic routes are the subject of a patent application, which intermediates are claimed, and what the competitive landscape looks like for commercial manufacturing profitability.
A Claimed Intermediate is a novel pharmaceutical process intermediate that is claimed within a process patent specification — often carrying the same 20-year patent protection term if the patent is granted.
Identifying and tracking Claimed Intermediates is essential for Generic Manufacturers, Patent Attorneys and Commercial Chemists assessing freedom to operate, synthesis design, and route development.
The Tcipatent database is the only resource specifically designed to locate, catalogue, and make searchable these claimed intermediates across thousands of process patent specifications for marketed drugs.
The Tcipatent platform is available as a subscription database and as tailored bespoke reports. Both products draw on the same expertly curated dataset covering process patents published from January 2010 onwards.
Full platform access with text & enhanced structure search
Subscription access to the complete Tcipatent database, updated on an ongoing basis as new process patents are published. Includes Monthly Reports as standard.
Monthly, quarterly, and bespoke patent intelligence reports
Structured patent intelligence reports drawn directly from the Tcipatent database, available as regular subscriptions or as fully customised bespoke reports to your specification.
The Tcipatent database includes a fully integrated chemical structure search tool, enabling users to search by SMILES or by drawing a structure directly in the Kekule editor below and search for Exact, Similarity, Derivative, or Substructure hits across the entire dataset. Derivative searching is clicking on a structure in a result set and editing.
Every record in the Tcipatent database is the result of expert human analysis — not automated scraping. This is what makes the platform uniquely valuable.
Newly published process patent specifications for marketed pharmaceutical drugs are identified across major jurisdictions as they are published.
Each specification is read and analysed by an experienced pharmaceutical patent professional. Drug synthetic routes are identified and any claimed intermediates extracted.
A structured database record is created including patent details, drug INN, patentee, claimed intermediates, structures, and basic patent status.
Only new patent specifications are added — equivalent family members are excluded to avoid duplication. Equivalents remain accessible via standard patent databases.
New records are published to the live platform, with subscribers notified via Monthly Reports.

Eddie Kehoe has been searching, examining, abstracting, and interpreting patent specifications for over 50 years. Initially trained as a Chemist, he has covered most patent subject areas but has focused principally on pharmaceutical patents.
Patents represent a uniquely complex intersection of technological and legal matter, requiring a specific professional discipline to quickly and effectively understand their scope, claims, and commercial implications. Eddie brings this expertise to every record in the Tcipatent database.
Tcipatent was established to make this specialist knowledge accessible in a practical, scalable platform — enabling Pharmaceutical Companies, Patent Attorneys, Generic Manufacturers and Commercial Chemists to access curated process patent intelligence without the cost and time burden of in-house analysis.
LinkedIn ProfileWhether you are looking for subscription access to the database, a bespoke patent intelligence report, or would like to discuss acquiring or partnering with Tcipatent Ltd, we welcome your enquiry.